EBVdb: a data mining system for knowledge discovery in Epstein-Barr virus with applications in T cell immunology and vaccinology

As the first cancer-causing human virus identified, Epstein-Barr virus (EBV) has been implicated in the development of a wide range of B cell lymphoproliferative disorders, a subset of T/NK cell lymphomas, and post-transplant lymphoproliferative disorders. We made use of the immunological data on EBV available through publications, technical reports, and databases and constructed Epstein-Barr virus T cell Antigen Database (EBVdb). EBVdb contains 2622 curated antigen entries of EBV antigenic proteins, 610 verified T cell epitopes and 26 verified HLA ligands. The data were subject to extensive quality control (redundancy elimination, error detection, and vocabulary consolidation). A set of computational tools for in-depth analysis, such as sequence comparison using BLAST search, multiple alignments of antigens, T cell epitope/HLA ligand visualization, T cell epitope/HLA ligand conservation analysis, and sequence variability analysis, have been integrated within the EBVdb. Predicted Class I and Class II HLA-binding peptides for 15 common HLA alleles are included in this database as putative targets. EBVdb seamlessly integrates curated data and information with tailored analysis tools to facilitate data mining for EBV vaccinology and immunology. EBVdb is a unique data source providing a comprehensive list of EBV antigens and peptides and is publicly available at http://projects.met-hilab.org/ebv/.

[1]  V. Brusic,et al.  FluKB: A Knowledge-Based System for Influenza Vaccine Target Discovery and Analysis of the Immunological Properties of Influenza Viruses , 2015, Journal of immunology research.

[2]  J. Cohen Epstein–barr virus vaccines , 2015, Clinical & translational immunology.

[3]  Deborah Hix,et al.  The immune epitope database (IEDB) 3.0 , 2014, Nucleic Acids Res..

[4]  Vladimir Brusic,et al.  Big Data Analytics in Immunology: A Knowledge-Based Approach , 2014, BioMed research international.

[5]  M. Rowe,et al.  Epstein Barr virus entry; kissing and conjugation. , 2014, Current opinion in virology.

[6]  Vladimir Brusic,et al.  HPVdb: a data mining system for knowledge discovery in human papillomavirus with applications in T cell immunology and vaccinology , 2013, BCB.

[7]  P. Farrell,et al.  Epstein-Barr Virus Sequence Variation—Biology and Disease , 2012, Pathogens.

[8]  Anthony Epstein Burkitt lymphoma and the discovery of Epstein–Barr virus , 2012, British journal of haematology.

[9]  V. Brusic,et al.  FLAVIdB: A data mining system for knowledge discovery in flaviviruses with direct applications in immunology and vaccinology , 2013, Immunome research.

[10]  W. Wilson,et al.  Characterization and treatment of chronic active Epstein-Barr virus disease: a 28-year experience in the United States. , 2011, Blood.

[11]  O. Lund,et al.  NetMHCIIpan-2.0 - Improved pan-specific HLA-DR predictions using a novel concurrent alignment and weight optimization training procedure , 2010, Immunome research.

[12]  G. Klein,et al.  Interaction of Epstein-Barr virus (EBV) with human B-lymphocytes. , 2010, Biochemical and biophysical research communications.

[13]  Hao Liu,et al.  Long-term outcome of EBV-specific T-cell infusions to prevent or treat EBV-related lymphoproliferative disease in transplant recipients. , 2010, Blood.

[14]  Baris E. Suzek,et al.  The Universal Protein Resource (UniProt) in 2010 , 2009, Nucleic Acids Res..

[15]  María Martín,et al.  The Universal Protein Resource (UniProt) in 2010 , 2010 .

[16]  E. Robertson Epstein-barr virus : latency and transformation , 2010 .

[17]  H. Heslop,et al.  Immunotherapy for Epstein-Barr Virus-Related Lymphomas , 2009, Mediterranean journal of hematology and infectious diseases.

[18]  Vladimir Brusic,et al.  Evaluation of MHC-II peptide binding prediction servers: applications for vaccine research , 2008, BMC Bioinformatics.

[19]  O. Lund,et al.  NetMHCpan, a method for MHC class I binding prediction beyond humans , 2008, Immunogenetics.

[20]  V. Brusic,et al.  Evaluation of MHC class I peptide binding prediction servers: Applications for vaccine research , 2008, BMC Immunology.

[21]  G. Klein,et al.  Epstein–Barr virus infection in humans: from harmless to life endangering virus–lymphocyte interactions , 2007, Oncogene.

[22]  Chung-Che Chang,et al.  Monoculture-derived T lymphocytes specific for multiple viruses expand and produce clinically relevant effects in immunocompromised individuals , 2006, Nature Medicine.

[23]  Gregory D. Schuler,et al.  Database resources of the National Center for Biotechnology Information: update , 2004, Nucleic acids research.

[24]  K. Katoh,et al.  MAFFT: a novel method for rapid multiple sequence alignment based on fast Fourier transform. , 2002, Nucleic acids research.

[25]  D. Srivastava,et al.  Infusion of cytotoxic T cells for the prevention and treatment of Epstein-Barr virus-induced lymphoma in allogeneic transplant recipients. , 1998, Blood.

[26]  R. Krance,et al.  Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr-virus-related lymphoproliferation , 1995, The Lancet.

[27]  E. Myers,et al.  Basic local alignment search tool. , 1990, Journal of molecular biology.

[28]  E. Kieff,et al.  Epstein-Barr virus types 1 and 2 differ in their EBNA-3A, EBNA-3B, and EBNA-3C genes , 1990, Journal of virology.

[29]  P. L. Deininger,et al.  DNA sequence and expression of the B95-8 Epstein—Barr virus genome , 1984, Nature.